Catalyst intelligence for single-asset therapeutics
Structured evidence chains for single-asset bets. Built for analysts who need to size catalysts with conviction.
Coming soonBuilt for analysts
Biosentinel surfaces what manual research often misses: structured insight, not just search. For those who need to size catalyst bets with conviction.
How it works
- Structured evidence, not noise - Precedents and risks in one place.
- Precedents that matter - From one asset to a curated set of comparators.
- Catalyst and risk together - Events, milestones, and what could move the needle.